[{"id": 137827, "created": "2022-01-01T00:04:30.939781", "project_id": 65, "task_id": 182073, "user_id": 168, "user_ip": null, "finish_time": "2022-01-01T00:06:25.719006", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"text": "Tek doz Biontech/Pfizer a\u015f\u0131s\u0131n\u0131n etkisi delta varyant\u0131na kar\u015f\u0131 % 35,5, \u0130ngiltere varyant\u0131na kar\u015f\u0131 ise % 51,1. \u0130ki dozdan sonra \u0130ngiltere varyant\u0131na kar\u015f\u0131 % 87,9, Hindistan varyant\u0131na kar\u015f\u0131 ise % 59,8. Gelen b\u00fct\u00fcn a\u015f\u0131y\u0131 1. doz olarak kullan\u0131p, https://t.co/VLmcJQZV7x", "file_id": "1410523059715555330", "classifier": {"q1": "yes", "q2": "IGNORED", "q3": "IGNORED", "q4": "IGNORED", "q5": "yes_not_urgent", "q6": "no_not_harmful", "q7": "no_not_interesting", "comment": ""}}}, {"id": 137997, "created": "2022-01-05T11:46:42.093315", "project_id": 65, "task_id": 182073, "user_id": 175, "user_ip": null, "finish_time": "2022-01-05T11:48:19.440409", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"text": "Tek doz Biontech/Pfizer a\u015f\u0131s\u0131n\u0131n etkisi delta varyant\u0131na kar\u015f\u0131 % 35,5, \u0130ngiltere varyant\u0131na kar\u015f\u0131 ise % 51,1. \u0130ki dozdan sonra \u0130ngiltere varyant\u0131na kar\u015f\u0131 % 87,9, Hindistan varyant\u0131na kar\u015f\u0131 ise % 59,8. Gelen b\u00fct\u00fcn a\u015f\u0131y\u0131 1. doz olarak kullan\u0131p, https://t.co/VLmcJQZV7x", "file_id": "1410523059715555330", "classifier": {"q1": "yes", "q2": "IGNORED", "q3": "IGNORED", "q4": "IGNORED", "q5": "yes_very_urgent", "q6": "yes_panic", "q7": "yes_classified_as_in_question_6", "comment": ""}}}, {"id": 154943, "created": "2022-02-09T20:46:56.084781", "project_id": 65, "task_id": 182073, "user_id": 180, "user_ip": null, "finish_time": "2022-02-09T20:48:21.968071", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"text": "Tek doz Biontech/Pfizer a\u015f\u0131s\u0131n\u0131n etkisi delta varyant\u0131na kar\u015f\u0131 % 35,5, \u0130ngiltere varyant\u0131na kar\u015f\u0131 ise % 51,1. \u0130ki dozdan sonra \u0130ngiltere varyant\u0131na kar\u015f\u0131 % 87,9, Hindistan varyant\u0131na kar\u015f\u0131 ise % 59,8. Gelen b\u00fct\u00fcn a\u015f\u0131y\u0131 1. doz olarak kullan\u0131p, https://t.co/VLmcJQZV7x", "file_id": "1410523059715555330", "classifier": {"q1": "no", "q6": "no_not_harmful", "q7": "not_sure", "comment": ""}}}]